Perrigo | PRGO - Current Liabilities


Perrigo reported $1.01B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Abbott USD 16.5B 1.91B Dec/2025
Bayer EUR 32.58B 3.63B Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Coherus Biosciences USD 140.39M 231.91M Dec/2025
Corcept Therapeutics USD 166.08M 6.18M Dec/2025
Dr.Reddys Laboratories INR 158.31B 7.38B Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
J&J USD 57.72B 3.59B Mar/2026
Merck USD 28.63B 2.59B Sep/2025
Nestle CHF 40.69B 6.13B Dec/2025
Pacira USD 120.59M 13.51M Dec/2025
Perrigo USD 1.01B 132.4M Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
Phibro Animal Health USD 282.37M 12.23M Dec/2025
Prestige Brands USD 139.56M 4.95M Dec/2025
Reckitt Benckiser GBP 7.94B 901M Dec/2024
Sanofi EUR 30.01B 1.66B Mar/2026
Supernus Pharmaceuticals USD 338.17M 7.54M Dec/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025
Xeris Pharmaceuticals USD 109.57M 6.63M Dec/2025
Zoetis USD 2.24B 428M Dec/2025